[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@NachoTrust](/creator/twitter/NachoTrust)
"@LPessa7654 @Jonny_fun_guy Many reasons why $imrx will never be $rvmd. Their own candidate has very little response in monotherapy for starters. Furthermore $rvmd has not even shown its 1L data yet I suspect its gonna be very good. Sell IMRX while you can"  
[X Link](https://x.com/NachoTrust/status/1976819081375629387) [@NachoTrust](/creator/x/NachoTrust) 2025-10-11T01:16Z 3600 followers, XXX engagements


"@broheim777 $imrx candidate as limited response in monotherapy plus no report of pfs. Data not even better than daraxonrasib mono in 2L setting. There are more players than $rvmd out there in the RAS - you should perhaps read up a little"  
[X Link](https://x.com/NachoTrust/status/1978573851870081297) [@NachoTrust](/creator/x/NachoTrust) 2025-10-15T21:29Z 3600 followers, XXX engagements


"@PeterSchiff @JamesHMackay why is bitcoin trading down bruuuuhh"  
[X Link](https://x.com/NachoTrust/status/1978976257128960119) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T00:08Z 3600 followers, XXX engagements


"@JamesHMackay @PeterSchiff I will buy and hopefully then it crashes"  
[X Link](https://x.com/NachoTrust/status/1978978782263345580) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T00:18Z 3600 followers, XX engagements


"@JamesHMackay @PeterSchiff A broken clock can be right some times too nows the time James. Get out while you still can"  
[X Link](https://x.com/NachoTrust/status/1978988242180378770) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T00:55Z 3600 followers, XX engagements


"@JamesHMackay @PeterSchiff Ok. Will be on the look out for that range"  
[X Link](https://x.com/NachoTrust/status/1979006182141382710) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T02:06Z 3600 followers, XX engagements


"@3PeaksTrading I think it can happen sooner rather than later. Merck needs this. Its just a year of keytruda revenue needed to get it $125-150/share instantly become a leader in the biggest oncology targets"  
[X Link](https://x.com/NachoTrust/status/1979007872810766337) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T02:13Z 3600 followers, XX engagements


"@bio_clouseau Seriously $rvmd has fully recruited its phase X 2L trial well ahead of schedule and plus this that a lot of saved time probably means $750m-1bn of earlier than expected revenue of not more which may result in not needing another equity issue"  
[X Link](https://x.com/NachoTrust/status/1979149635995472200) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T11:36Z 3600 followers, XXX engagements